Clinical Trial Update: Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating pembrolizumab in combination with bevacizumab and CapeOX as neoadjuvant therapy for locally advanced colorectal cancer; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• Capecitabine (Xeloda) (Capecitabine)
• Oxaliplatin (Eloxatin) (oxaliplatin)
• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: yangjianjun | Conditions: Locally Advanced Colorectal Cancer | Phase 4 | Status: RECRUITING